Suchergebnisse - "La Rosée, Paul"

PubPharm (199)

1

Value of hemophagocytosis in the diagnosis of hemophagocytic lymphohistiocytosis in critically ill patients

enthalten in: European journal of haematology | 2024

von Nyvlt, P. | Schuster, F. | Ihlow, J. | +11

2

Lymphoma-associated hemophagocytic lymphohistiocytosis (LA-HLH) : a scoping review unveils clinical and diagnostic patterns of a lymphoma subgroup with poor prognosis

enthalten in: Leukemia | 2024

von Knauft, J. | Schenk, T. | Ernst, T. | +4

3

Final Results from RIBBIT : A Randomized Phase III Study to Evaluate Efficacy and Quality of Life in Patients with Metastatic Hormone Receptor-Positive, HER2-Negative Breast Cancer Receiving Ribociclib in Combination with Endocrine Therapy or Chemotherapy with or without Bevacizumab in the First-Line Setting

enthalten in: Breast care (Basel, Switzerland) | 2024

von Decker, T. | Zaiss, M. | Klein, D. | +12

4

A prospective observational study of real-world treatment and outcome in secondary CNS lymphoma

enthalten in: European journal of cancer (Oxford, England : 1990) | 2024

von Habringer, S. | Demel, U. | Fietz, A. | +35

5

Elotuzumab, lenalidomide, bortezomib, dexamethasone, and autologous haematopoietic stem-cell transplantation for newly diagnosed multiple myeloma (GMMG-HD6) : results from a randomised, phase 3 trial

enthalten in: The Lancet. Haematology | 2024

von Mai, E. | Goldschmid, H. | Miah, K. | +74

ErratumIn: Lancet Haematol. 2024 Feb 7;:. - PMID 38340740

6

10-day decitabine versus 3 + 7 chemotherapy followed by allografting in older patients with acute myeloid leukaemia : an open-label, randomised, controlled, phase 3 trial

enthalten in: The Lancet. Haematology | 2023

von Lübbert, M. | Wijermans, P. | Kicinski, M. | +83

CommentIn: Lancet Haematol. 2023 Nov;10(11):e866-e867. - PMID 37914474

7

Treatment of hemophagocytic lymphohistiocytosis in patients in the intensive care unit

enthalten in: Innere Medizin (Heidelberg, Germany) | 2023

von Eichenauer, D. | La Rosée, P.

8

Addendum to the German Consensus Recommendations on Ponatinib in the Treatment of Chronic Myeloid Leukemia

enthalten in: Acta haematologica | 2023

von Saussele, S. | La Rosée, P. | Kiani, A. | +10

ErratumIn: Acta Haematol. 2024;147(2):249. - PMID 38412838

9

Addendum to the German consensus recommendations on ponatinib in the treatment of chronic myeloid leukemia : review

enthalten in: Acta haematologica | October 17, 2023

von Saußele, S. | La Rosée, P. | Kiani, A. | +10

10

Differential Diagnosis of Hyperferritinemia in Critically Ill Patients

enthalten in: Journal of clinical medicine | 2022

von Schuster, F. | Nyvlt, P. | Heeren, P. | +8

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[20]